StockNews.com downgraded shares of iCAD (NASDAQ:ICAD – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning.
iCAD Price Performance
Shares of ICAD stock opened at $1.68 on Wednesday. The stock’s 50-day moving average is $1.34 and its 200 day moving average is $1.49. iCAD has a 1-year low of $1.18 and a 1-year high of $2.65. The company has a market cap of $44.59 million, a P/E ratio of -14.00 and a beta of 1.50.
Hedge Funds Weigh In On iCAD
Institutional investors and hedge funds have recently bought and sold shares of the company. Virtu Financial LLC grew its stake in iCAD by 55.6% during the 1st quarter. Virtu Financial LLC now owns 21,286 shares of the technology company’s stock worth $34,000 after buying an additional 7,604 shares during the last quarter. Salem Investment Counselors Inc. purchased a new stake in shares of iCAD during the first quarter worth about $119,000. AMH Equity Ltd acquired a new position in shares of iCAD during the first quarter valued at about $207,000. Perritt Capital Management Inc raised its position in shares of iCAD by 14.2% in the 2nd quarter. Perritt Capital Management Inc now owns 159,900 shares of the technology company’s stock valued at $208,000 after purchasing an additional 19,917 shares during the last quarter. Finally, Perritt Capital Management Inc. boosted its stake in iCAD by 7.5% in the 1st quarter. Perritt Capital Management Inc. now owns 139,983 shares of the technology company’s stock worth $225,000 after purchasing an additional 9,717 shares in the last quarter. 24.61% of the stock is owned by hedge funds and other institutional investors.
iCAD Company Profile
iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.
Featured Stories
- Five stocks we like better than iCAD
- Technology Stocks Explained: Here’s What to Know About Tech
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 8/12 – 8/16
- Which Wall Street Analysts are the Most Accurate?
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for iCAD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCAD and related companies with MarketBeat.com's FREE daily email newsletter.
